ZDHHC20 and neoplasm: However, they found that inhibition of zDHHC20-mediated palmitoylation of EGFR contributed to the maintenance of EGFR signaling, promoting the survival, growth and metastasis of tumor cells, and further sensitizing the efficacy of TKIs 18.